Want to see CLOV full AI Analyst Report?
Revenue by Segment
Separates revenue into lines like Medicare Advantage premiums versus platform or services revenue. Identifies which activities drive top-line growth and which deliver higher margins. A shift toward service or platform revenue can improve profitability and diversify risk, whereas dependence on premium revenue makes results more sensitive to medical costs and regulatory changes.Clover has shifted from a mix of non‑insurance and premium revenue to being overwhelmingly premium‑driven: Non‑Insurance Revenue collapsed to zero after 2023 (likely one‑offs or discontinued activities), while Premiums Earned surged in 2025, signaling membership/market share growth. That improves top‑line predictability but concentrates risk on medical cost trends and Medicare policy/underwriting performance. The small, volatile “Other” line (notably the Sept‑2025 spike) looks like a one‑time item—track margins and guidance to judge whether higher premiums convert to durable profit.
Date | Other | Premiums Earned | Non-Insurance Revenue |
|---|---|---|---|
Jun 30, 2026 | $5.40M | $737.77M | $0.00 |
Mar 31, 2026 | $5.00M | $744.19M | $0.00 |
Dec 31, 2025 | $1.83M | $485.87M | $0.00 |
Sep 30, 2025 | $17.52M | $479.13M | $0.00 |
Jun 30, 2025 | $7.79M | $469.83M | $0.00 |
Mar 31, 2025 | $5.42M | $456.91M | $0.00 |
Dec 31, 2024 | $6.28M | $330.68M | $0.00 |
Sep 30, 2024 | $8.41M | $322.58M | $0.00 |
Jun 30, 2024 | $6.36M | $349.90M | $0.00 |
Mar 31, 2024 | $5.20M | $341.72M | $0.00 |